Sharps Technology, Inc.

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company headquartered in Melville, New York. The company's core business involves providing smart-safety syringe products to the healthcare industry, aiming to deliver practical solutions that enhance efficiency and safety in drug delivery.

Sharps Technology's product portfolio includes patented smart-safety syringes such as SoloGard™, designed for ultra-low waste and re-use prevention, SecureGard™ for advanced needlestick injury prevention, and the Provensa™ line of intuitive safety syringes. The company also develops prefillable polymer syringes utilizing specialized copolymer technology and offers pharmaceutical services, providing end-to-end solutions for its partners.

In addition to its medical device operations, Sharps Technology has established a significant digital asset treasury strategy, focusing on the accumulation of Solana (SOL) tokens. As of late 2025, the company held over 2 million SOL, valued at more than $400 million, and has formed partnerships with Coinbase and BitGo for institutional custody and staking services. Recent corporate activities include a $100 million stock repurchase program announced in October 2025 and a 1-for-300 reverse stock split in April 2025. The company also secured a $50 million supply agreement for its SoloGard syringes in July 2024, with initial commercial shipments commencing in 2025. Paul Kruger Danner serves as the Executive Chairman and Principal Executive & Financial Officer.